Tupperware Brands Corp
Change company Symbol lookup
Select an option...
TUP Tupperware Brands Corp
AKRO Akero Therapeutics Inc
MRTX Mirati Therapeutics Inc
SIRC Solar Integrated Roofing Corp
CHSTY China High Speed Transmission Equipment Group Co Ltd
TTMZF Datable Technology Corp
WVFC W V S Financial Corp
WHLM Wilhelmina International Inc
SON Sonoco Products Co
VIRX Viracta Therapeutics Inc
Go

Consumer Discretionary : Household Durables | Small Cap Value
Company profile

Tupperware Brands Corporation is a global consumer products company. The Company is engaged in the marketing, manufacturing and selling design-centric preparation, storage, and serving solutions for the kitchen and home through the Tupperware brand name. The Company primarily designs functional products to help store, serve, and prepare food. The Company operates its business through four geographic regions: Asia Pacific, Europe (Europe, Africa and the Middle East), North America, and South America. Its Tupperware brand product line consists of cookware, knives, microwave products, microfiber textiles, water-filtration-related items, and an array of products for on-the-go consumers. Its products include XtremAqua Freezable Bottle, Universal Cookware set, SuperSonic Choppers and others. The Company distributes its products into approximately 70 countries primarily through independent representatives around the world.

Premarket

Last Trade
Delayed
$4.72
-0.01 (-0.21%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.73
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
72

10-day average volume:
996,868
72

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Kiromic BioPharma, Inc. with Losses of $100,000 to Contact the Firm

9:45 am ET October 3, 2022 (Newsfile) Print

Los Angeles, California--(Newsfile Corp. - October 3, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Kiromic BioPharma, Inc. ("Kiromic" or "the Company") (NASDAQ: KRBP) for violations of the federal securities laws.

Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on July 2, 2021 (the "IPO"), and/or between June 25, 2021 and August 13, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before October 4, 2022.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Kiromic received communications from the FDA on June 16 and 17, 2021, placing a clinical hold on its two candidate products. The Company failed to inform investors of this clinical hold despite the fact it learned of the hold before the IPO occurred. The Company's IPO offering documents stated that clinical testing would move forward in the third quarter of 2021. The Company did not proceed with this test due to the clinical hold. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Kiromic, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE:

The Schall Law Firm

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/139246

comtex tracking

COMTEX_415809656/2523/2022-10-03T09:45:04

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.